Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Taiwan Bio Therapeutics Co., Ltd. (6892) Income Statement

Taiwan Bio Therapeutics Co., Ltd. Income Statement

Last quarter (Q2 2025), Taiwan Bio Therapeutics Co., Ltd.'s total revenue was NT$13.58M, an increase of 12.27% from the same quarter last year. In Q2, Taiwan Bio Therapeutics Co., Ltd.'s net income was NT$-116.39M. See Taiwan Bio Therapeutics Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 50.43MNT$ 105.09MNT$ 85.47MNT$ 44.74MNT$ 27.16M
NT$ 32.14MNT$ 56.07MNT$ 76.36MNT$ 31.67MNT$ 22.65M
NT$ 417.47MNT$ 407.51MNT$ 290.96MNT$ 218.32MNT$ 109.69M
Depreciation and AmortizationNT$ 125.35MNT$ 99.20MNT$ 66.23MNT$ 53.13MNT$ 28.91M
NT$ -259.98MNT$ -247.39MNT$ -145.97MNT$ -129.47MNT$ -58.44M
NT$ -385.33MNT$ -351.44MNT$ -212.20MNT$ -182.60MNT$ -87.34M
NT$ 3.73MNT$ -360.00KNT$ -5.31MNT$ -5.42MNT$ -2.86M
NT$ -381.60MNT$ -351.80MNT$ -217.51MNT$ -188.02MNT$ -90.20M
NT$ -381.65MNT$ -351.80MNT$ -217.51MNT$ -188.56MNT$ -90.20M
Per Share Metrics
Basic EPSNT$ -4.51NT$ -4.72NT$ -3.81NT$ -3.79NT$ -3.03
Diluted EPSNT$ -4.51NT$ -4.72NT$ -3.81NT$ -3.79NT$ -3.03
Weighted Average Shares Outstanding84.62M74.51M57.09M49.73M29.73M
Weighted Average Shares Outstanding (Diluted)84.62M74.51M57.09M49.73M29.73M

Currency in TWD

Taiwan Bio Therapeutics Co., Ltd. Earnings and Revenue History

-500M-250M0250M-800 %-600 %-400 %-200 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin